BioGeneric Pharma S.A.E (BGP) as an international, new state of the art biopharmaceutical corporate firmly commits to operate Integrated Management System in accordance with the requirements of ISO9001:2015, ISO14001:2015, ISO45001:2018, ISO27001:2022 PAS 99: 2012, international standards of cGMP in compliance with US FDA, EMA and WHO requirements, contractual requirements, applicable regulations and other requirements.

BGP is considered to be a world class biopharmaceutical production facility with different production lines that operates under global regulatory, quality and safety standards guaranteeing information security, products quality accompanied by an environment-friendly production and testing system and providing a safe workplace.

BGP’s aim is to develop, manufacture, analyse and market biopharmaceutical drug products and vaccines in a consistent affordable price all the way through products’ life cycle, focusing on continual improvement through programs appropriate to the nature and scale of risks and aspects and ensuring customer satisfaction, security of information, preservation of the environment; avoiding pollution, injury and ill health and complying with laws, regulations and other requirements.

BGP is built on an experienced team of experts from various areas of biotechnology and quality capable of facing any challenges that may occur within the fast-growing biotech field.

BGP believes in the diverse contributions of employees and provides extra ordinary value to the customers, community, shareholders and other relevant interested parties.

The security of data and information of the organization is BGP’s priority, and BGP is committed to safeguard and maintain it.